We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-2.98%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$251M
AUM Growth
-$19M
Cap. Flow
-$2.24M
Cap. Flow %
-0.89%
Top 10 Hldgs %
7.1%
Holding
477
New
43
Increased
256
Reduced
137
Closed
41

Top Buys

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$962K
2
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$944K
3
ENPH icon
Enphase Energy
ENPH
+$834K
4
DVN icon
Devon Energy
DVN
+$751K
5
IT icon
Gartner
IT
+$742K

Top Sells

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$785K
2
LHX icon
L3Harris
LHX
+$740K
3
A icon
Agilent Technologies
A
+$713K
4
CPRT icon
Copart
CPRT
+$688K
5
CQP icon
Cheniere Energy
CQP
+$687K

Sector Composition

Rank Sector Weight
1 Healthcare 18.83%
2 Real Estate 17.55%
3 Materials 12.77%
4 Financials 9.88%
5 Energy 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PMVP icon
376
PMV Pharmaceuticals
PMVP
$57.6M
$132K 0.05%
11,061
+75
+0.7% +$1.08K
DSGN icon
377
Design Therapeutics
DSGN
$743M
$130K 0.05%
7,775
+59
+0.8% +$1.17K
IOVA icon
378
Iovance Biotherapeutics
IOVA
$2.03B
$130K 0.05%
13,519
+104
+0.8% +$1.2K
ARVN icon
379
Arvinas
ARVN
$525M
$129K 0.05%
2,900
+20
+0.7% +$971
CYTK icon
380
Cytokinetics
CYTK
$10.7B
$129K 0.05%
2,665
+18
+0.7% +$866
ANAB icon
381
AnaptysBio
ANAB
$1.53B
$128K 0.05%
5,027
+42
+0.8% +$985
EDIT icon
382
Editas Medicine
EDIT
$391M
$128K 0.05%
10,440
+70
+0.7% +$1.09K
STOK icon
383
Stoke Therapeutics
STOK
$1.8B
$128K 0.05%
9,970
+75
+0.8% +$1.2K
KDNY
384
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$128K 0.05%
6,490
+49
+0.8% +$983
FATE icon
385
Fate Therapeutics
FATE
$267M
$126K 0.05%
5,607
+41
+0.7% +$1.19K
INO icon
386
Inovio Pharmaceuticals
INO
$83.9M
$125K 0.05%
6,045
+44
+0.7% +$1.13K
TVRD
387
Tvardi Therapeutics
TVRD
$22.1M
$125K 0.05%
372
+3
+0.8% +$1.09K
ALLO icon
388
Allogene Therapeutics
ALLO
$604M
$124K 0.05%
11,462
+79
+0.7% +$1.07K
ARWR icon
389
Arrowhead Research
ARWR
$12B
$124K 0.05%
3,742
+24
+0.6% +$969
IVVD icon
390
Invivyd
IVVD
$163M
$124K 0.05%
39,564
+283
+0.7% +$1.13K
REPL icon
391
Replimune Group
REPL
$426M
$124K 0.05%
7,153
+45
+0.6% +$858
ALEC icon
392
Alector
ALEC
$169M
$123K 0.05%
12,995
+97
+0.8% +$1.05K
RVMD icon
393
Revolution Medicines
RVMD
$38.1B
$123K 0.05%
6,214
+45
+0.7% +$989
IMGO
394
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$123K 0.05%
8,189
+55
+0.7% +$892
CRNX icon
395
Crinetics Pharmaceuticals
CRNX
$8.88B
$122K 0.05%
6,228
+48
+0.8% +$979
MGTX icon
396
MeiraGTx Holdings
MGTX
$1.07B
$121K 0.05%
14,362
+98
+0.7% +$864
CERE
397
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$121K 0.05%
4,295
+36
+0.8% +$1.07K
ARCT icon
398
Arcturus Therapeutics
ARCT
$160M
$120K 0.05%
8,092
+53
+0.7% +$889
PTGX icon
399
Protagonist Therapeutics
PTGX
$8.66B
$120K 0.05%
14,237
+108
+0.8% +$1.02K
CMPS
400
Compass Pathways
CMPS
$1.45B
$119K 0.05%
11,061
+75
+0.7% +$1.12K
14 15
16
17 18

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Virtus ETF Advisers held 477 positions worth $251M, down 7% from $270M the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

Virtus ETF Advisers's Q3 2022 filing shows 43 new, 256 increased, 137 reduced and 41 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 11,040 shares worth $877K. The largest sale was Moderna, an estimated $785K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Real Estate and Materials.

  • Virtus ETF Advisers's largest Q3 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 11,040 shares worth $877K.
  • Virtus ETF Advisers added most to The Mosaic Company in Q3 2022, an estimated $962K increase.
  • Virtus ETF Advisers's biggest Q3 2022 reduction was Moderna, cutting an estimated $785K.
  • Virtus ETF Advisers fully exited L3Harris in Q3 2022, selling an estimated $740K.
  • Virtus ETF Advisers's ten largest holdings make up 7.1% of its $251M portfolio in Q3 2022.
  • Virtus ETF Advisers opened 43 new positions and closed 41 in Q3 2022.
  • Virtus ETF Advisers's portfolio value fell 7% quarter-over-quarter to $251M.

Based on Virtus ETF Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.